MILLENNIUM MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 217 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,945,264
+159.5%
756,912
+396.8%
0.00%
Q1 2024$749,636
+548.3%
152,365
+1058.2%
0.00%
Q4 2023$115,632
-96.3%
13,155
-95.2%
0.00%
-100.0%
Q3 2023$3,145,934
-67.5%
274,275
-28.3%
0.00%
-50.0%
Q2 2023$9,687,605
+267070.6%
382,758
+240.0%
0.00%
+100.0%
Q1 2023$3,626
-60.5%
112,567
-77.4%
0.00%
-60.0%
Q4 2022$9,190
-99.9%
497,829
+82.6%
0.01%
+25.0%
Q3 2022$7,359,000
+13.3%
272,583
-42.0%
0.00%0.0%
Q2 2022$6,497,000
+149.6%
470,124
+252.2%
0.00%
+300.0%
Q1 2022$2,603,000
+350.3%
133,479
+543.2%
0.00%
Q3 2021$578,000
+7.2%
20,751
+7.5%
0.00%
Q1 2021$539,000
-86.8%
19,298
-86.6%
0.00%
-100.0%
Q4 2020$4,081,000
+548.8%
144,005
+476.0%
0.00%
+200.0%
Q3 2020$629,000
-64.5%
25,000
-77.1%
0.00%
-50.0%
Q4 2019$1,772,000
+246.1%
109,199
+177.2%
0.00%
+100.0%
Q3 2019$512,000
+4.3%
39,400
+26.5%
0.00%0.0%
Q1 2019$491,000
-93.8%
31,158
-92.0%
0.00%
-91.7%
Q4 2018$7,882,000
-49.7%
391,549
-37.9%
0.01%
-36.8%
Q3 2018$15,672,000
-47.3%
630,656
-41.8%
0.02%
-51.3%
Q2 2018$29,744,000
-35.4%
1,083,574
-27.5%
0.04%
-36.1%
Q1 2018$46,029,000
-6.7%
1,494,441
+8.3%
0.06%
-10.3%
Q4 2017$49,329,000
+10600.4%
1,379,832
+7797.8%
0.07%
+6700.0%
Q2 2017$461,000
-2.3%
17,471
-23.1%
0.00%0.0%
Q1 2017$472,000
-54.8%
22,705
-55.0%
0.00%
-50.0%
Q4 2016$1,045,000
-35.7%
50,502
-45.8%
0.00%
-50.0%
Q1 2016$1,626,000
-59.6%
93,115
-21.0%
0.00%
-50.0%
Q4 2015$4,026,000
-23.5%
117,850
-33.3%
0.01%
-20.0%
Q3 2015$5,262,000
-37.3%
176,801
-32.7%
0.01%
-37.5%
Q2 2015$8,398,000
+1938.3%
262,609
+1220.3%
0.02%
+1500.0%
Q1 2015$412,000
-71.9%
19,890
-77.0%
0.00%
-66.7%
Q4 2014$1,466,000
-50.8%
86,552
-43.8%
0.00%
-62.5%
Q3 2014$2,977,000
-27.3%
153,984
+27.8%
0.01%
-27.3%
Q2 2014$4,096,000
-59.5%
120,473
-62.5%
0.01%
-62.1%
Q1 2014$10,114,000321,0820.03%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,800,000$7,196,0006.61%
Palo Alto Investors LP 5,257,086$13,510,7111.57%
Lane Generational LLC 319,322$820,6580.97%
CM Management, LLC 400,000$1,028,0000.94%
AlphaCentric Advisors LLC 245,000$629,6500.46%
Essex Woodlands Management, Inc. 457,085$1,174,7080.38%
DCF Advisers, LLC 250,000$642,5000.33%
Ghost Tree Capital, LLC 225,000$578,2500.18%
Rubric Capital Management LP 2,656,847$6,828,0970.18%
Rhenman & Partners Asset Management AB 701,707$1,803,3870.17%
View complete list of REVANCE THERAPEUTICS INC shareholders